A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART

NCT02454556 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Infertility

Interventions

DRUG: FOLITIME®
DRUG: Gonal-F®

Sponsor

Gema Biotech S.A.

Collaborators

[object Object]